384 related articles for article (PubMed ID: 24147202)
1. Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management.
Pappachan JM; Varughese GI; Sriraman R; Arunagirinathan G
World J Diabetes; 2013 Oct; 4(5):177-89. PubMed ID: 24147202
[TBL] [Abstract][Full Text] [Related]
2. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
[TBL] [Abstract][Full Text] [Related]
3. Serum Annexin A2 concentrations are increased in patients with diabetic cardiomyopathy and are linked to cardiac dysfunctions.
He Q; Zhu J; Yang G; Liu X; Li L; Wang Y; Xiong X; Zheng Y; Zheng H; Qu H
Diabetes Res Clin Pract; 2023 Jan; 195():110196. PubMed ID: 36464090
[TBL] [Abstract][Full Text] [Related]
4. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes.
Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR
Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767
[TBL] [Abstract][Full Text] [Related]
5. Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology.
Heather LC; Gopal K; Srnic N; Ussher JR
Diabetes; 2024 May; 73(5):659-670. PubMed ID: 38387045
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center.
Swiatkiewicz I; Patel NT; Villarreal-Gonzalez M; Taub PR
BMC Med; 2024 May; 22(1):195. PubMed ID: 38745169
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiography.
Dinh W; Füth R; Lankisch M; Bansemir L; Nickl W; Scheffold T; Bufe A; Krahn T; Ziegler D
Diabet Med; 2011 Mar; 28(3):311-8. PubMed ID: 21204960
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
Segar MW; Khan MS; Patel KV; Butler J; Tang WHW; Vaduganathan M; Lam CSP; Verma S; McGuire DK; Pandey A
J Am Coll Cardiol; 2021 Oct; 78(16):1587-1598. PubMed ID: 34649696
[TBL] [Abstract][Full Text] [Related]
11. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms and Epigenetic Regulation in Diabetic Cardiomyopathy.
Mittal A; Garg R; Bahl A; Khullar M
Front Cardiovasc Med; 2021; 8():725532. PubMed ID: 34977165
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Predictors of Subclinical Cardiomyopathy in Patients With Type 2 Diabetes in a Health System.
Nagori A; Segar MW; Keshvani N; Patel L; Patel KV; Chandra A; Willett D; Pandey A
J Diabetes Sci Technol; 2023 Dec; ():19322968231212219. PubMed ID: 38063209
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance T1 Mapping: Correlation with Left-Ventricular Diastolic Dysfunction and Diabetic Duration.
Shang Y; Zhang X; Leng W; Chen L; Lei X; Zhang T; Greiser A; Liang Z; Wang J
J Diabetes Res; 2017; 2017():9584278. PubMed ID: 28791311
[TBL] [Abstract][Full Text] [Related]
16. Histological and proteomic profile of diabetic versus non-diabetic dilated cardiomyopathy.
Frustaci A; Ciccosanti F; Chimenti C; Nardacci R; Corazzari M; Verardo R; Ippolito G; Petrosillo N; Fimia GM; Piacentini M
Int J Cardiol; 2016 Jan; 203():282-9. PubMed ID: 26519687
[TBL] [Abstract][Full Text] [Related]
17. Potential clinical value of fibrinogen-like protein 1 as a serum biomarker for the identification of diabetic cardiomyopathy.
Liu Y; Wang M; Su JB; Fu X; Zheng GL; Guo S; Zhang LJ; Lu QB
Sci Rep; 2024 May; 14(1):10311. PubMed ID: 38705920
[TBL] [Abstract][Full Text] [Related]
18. Diabetic heart disease: A clinical update.
Rajbhandari J; Fernandez CJ; Agarwal M; Yeap BXY; Pappachan JM
World J Diabetes; 2021 Apr; 12(4):383-406. PubMed ID: 33889286
[TBL] [Abstract][Full Text] [Related]
19. Diabetic cardiomyopathy--fact or fiction?
Maisch B; Alter P; Pankuweit S
Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
[TBL] [Abstract][Full Text] [Related]
20. Diabetic Cardiomyopathy; Summary of 41 Years.
Yilmaz S; Canpolat U; Aydogdu S; Abboud HE
Korean Circ J; 2015 Jul; 45(4):266-72. PubMed ID: 26240579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
